Docoh
Loading...

KALA Kala Pharmaceuticals

Filed: 14 Oct 21, 5:00pm
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

SCHEDULE 13G

(Amendment No. 4)*

 

Under the Securities Exchange Act of 1934




 

Kala Pharmaceuticals Inc.
(Name of Issuer)

 

 

Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)

 

 

483119103
(CUSIP Number)

 

 

October 12, 2021
(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o  Rule 13d-1(b)

x Rule 13d-1(c)

o  Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
   

 

CUSIP No. 483119103 SCHEDULE 13GPage 2 of 8 Pages
     
1

NAME OF REPORTING PERSONS

 

OrbiMed Capital GP VI LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

 
3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

o
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12

TYPE OF REPORTING PERSON

 

OO

 

 

 

 

 

 

 

   

 

CUSIP No. 483119103 SCHEDULE 13GPage 3 of 8 Pages
     
1

NAME OF REPORTING PERSONS

 

OrbiMed Advisors LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

 
3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

o
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12

TYPE OF REPORTING PERSON

 

IA

 

 

 

 

 

 

 

 

   

 

CUSIP No. 483119103 SCHEDULE 13GPage 4 of 8 Pages
     
1

NAME OF REPORTING PERSONS

 

OrbiMed Capital LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

 
3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

o
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12

TYPE OF REPORTING PERSON

 

IA

 

 

 

 

 

 

 

 

   

 

CUSIP No.  483119103 SCHEDULE 13GPage 5 of 8 Pages

 

 

Item 1. (a) Name of Issuer:

Kala Pharmaceuticals, Inc.

  (b) Address of Issuer’s Principal Executive Offices:

100 Beaver Street, Suite 201

Waltham, MA 02453

Item 2. (a) Name of Person Filing:

OrbiMed Capital GP VI LLC

OrbiMed Advisors LLC

OrbiMed Capital LLC

  (b) Address of Principal Business Office:

601 Lexington Avenue, 54th Floor

New York, NY 10022

  (c) Citizenship:

Please refer to Item 4 on each cover page for each Reporting Person.

  (d) Title of Class of Securities:

Common Stock, Par Value $0.001 Per Share

  (e) CUSIP No.:

483119103

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

CUSIP No. 483119103 SCHEDULE 13GPage 6 of 8 Pages

 

 

Item 3.      

OrbiMed Capital GP VI LLC (“GP VI”) is the general partner of OrbiMed Private Investments VI, LP. OrbiMed Advisors LLC (“Advisors”) and OrbiMed Capital LLC (“Capital”) are investment advisors in accordance with ss.240.13d-1(b)(1)(ii)(E) and Advisors is the managing member of GP VI.

Item 4. Ownership:

Information with respect to the Reporting Person’s ownership as of October 12, 2021 is incorporated by reference to items (5) - (9) and (11) of the cover page for the Reporting Person.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [✓].

Item 6. Ownership of More Than Five Percent on Behalf of Another Person. 

Not applicable.

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. 

Not applicable.

Item 8. Identification and Classification of Members of the Group. 

Not applicable.

Item 9. Notice of Dissolution of Group. 

Not applicable.

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 

   

 

CUSIP No. 483119103 SCHEDULE 13GPage 7 of 8 Pages

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: October 14, 2021

 

 

 OrbiMed Advisors LLC
    
 By: /s/ Carl Gordon
  Name: Carl Gordon
  Title: Member
    
    
 OrbiMed Capital GP VI LLC
 By: OrbiMed Advisors LLC, its Managing Member
    
    
 By:/s/ Carl Gordon
  Name: Carl Gordon
  Title: Member of OrbiMed Advisors LLC

 

 

 OrbiMed Capital LLC
    
 By: /s/ Carl Gordon
  Name: Carl Gordon
  Title: Member